Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy (Second Edition) - Ghana (GNDP; 2004; 37 pages)
View the documentPREFACE
View the documentACKNOWLEDGEMENT
View the documentLIST OF ACRONYMS
View the documentINTRODUCTION
View the documentGOAL
View the documentOBJECTIVES
View the documentSITUATIONAL ANALYSIS
Open this folder and view contents1.0 DRUG SELECTION
Open this folder and view contents2.0 DRUG PROCUREMENT, STORAGE AND DISTRIBUTION
close this folder3.0 DRUG FINANCING
View the document3.1 Preamble
View the document3.2 Objective
View the document3.3 Policy Statement
Open this folder and view contents4.0 QUALITY ASSURANCE
Open this folder and view contents5.0 LOCAL MANUFACTURE OF PHARMACEUTICAL AND TRADITIONAL MEDICINAL PRODUCTS
Open this folder and view contents6.0 RATIONAL DRUG USE
Open this folder and view contents7.0 GLOBAL TRADE AND PHARMACEUTICALS
Open this folder and view contents8.0 EMERGING DISEASES AND PHARMACEUTICALS
Open this folder and view contents9.0 HUMAN RESOURCE DEVELOPMENT FOR DRUG MANAGEMENT
Open this folder and view contents10.0 TRADITIONAL MEDICINAL PRODUCTS
Open this folder and view contents11.0 RESEARCH AND DEVELOPMENT
Open this folder and view contents12.0 NATIONAL DRUG POLICY IMPLEMENTATION
View the documentANNEX A: DEFINITIONS
View the documentANNEX B: RELEVANT REGULATIONS ON PHARMACEUTICALS
 

3.3 Policy Statement

3.3.1 Government shall continue to finance the procurement and management of adequate quantities of good quality essential drugs in the public sector.

3.3.2 Government shall collaborate with the private sector and donor agencies in the funding of drug supplies to the public sector.

3.3.3 Whilst the principle of cost recovery of drugs shall be retained, appropriate mechanisms shall be put in place to offer subsidies and exemptions for payment of drugs for specified categories of patients.

3.3.4 Health Insurance schemes shall be established to facilitate access to drugs at service delivery points.

3.3.5 Government shall exempt selected essential drugs from Value Added Tax (VAT) and other forms of taxation. Such exempted drugs shall be reviewed periodically, but not beyond two years.

3.3.6 Raw materials used for local manufacturing shall be subject to VAT exemption on conditions to be determined by parliament.

3.3.7 Government shall ensure that essential drugs are affordable and a national pricing policy put in place.

to previous sectionto next section

Please provide your feedback English  |  French